Ligand-independent c-Met phosphorylation, which is activated by EGFR in NSCLC [10], could induce interaction with mutant K-ras, and this would not be inhibited by a HGF NA, a possible reason for resistance. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.